Silo Pharma, Inc.(SILO)
Biotechnology
Neuroscience Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-12-16 | Weisblum Eric Chief Executive Officer | Purchase | +5,000 | +2.36%216,932 | $0.41 | $2,075 | View SEC filing | |
| 2025-11-21 | Weisblum Eric Chief Executive Officer | Purchase | +2,000 | +0.95%211,932 | $0.37 | $735 | View SEC filing | |
| 2025-11-20 | Weisblum Eric Chief Executive Officer | Purchase | +12,000 | +6.06%209,932 | $0.40 | $4,847 | View SEC filing | |
| 2025-05-28 | Weisblum Eric Chief Executive Officer | Purchase | +10,000 | +5.32%197,932 | $0.43 | $4,329 | View SEC filing | |
| 2024-12-16 | Weisblum Eric CEO and President | Purchase | +2,500 | +1.35%187,932 | $0.84 | $2,097 | View SEC filing | |
| 2024-11-22 | Weisblum Eric CEO and President | Purchase | +5,000 | +2.77%185,432 | $0.93 | $4,625 | View SEC filing | |
| 2024-06-13 | Weisblum Eric CEO and President | Purchase | +5,000 | +2.85%180,432 | $1.11 | $5,533 | View SEC filing | |
| 2024-04-08 | Weisblum Eric CEO and President | Purchase | +1,000 | +0.57%175,432 | $1.99 | $1,988 | View SEC filing | |
| 2024-04-01 | Weisblum Eric CEO and President | Purchase | +4,508 | +2.65%174,432 | $1.93 | $8,713 | View SEC filing | |
| 2023-12-21 | Weisblum Eric CEO and President | Purchase | +700 | +0.41%169,924 | $1.62 | $1,137 | View SEC filing | |
| 2023-12-18 | Weisblum Eric CEO and President | Purchase | +1,100 | +0.65%169,224 | $1.52 | $1,668 | View SEC filing | |
| 2023-12-07 | Weisblum Eric CEO and President | Purchase | +1,000 | +0.60%168,124 | $1.38 | $1,376 | View SEC filing | |
| 2023-11-30 | Weisblum Eric CEO and President | Purchase | +2,000 | +1.21%167,124 | $1.55 | $3,100 | View SEC filing | |
| 2023-11-27 | Weisblum Eric CEO and President | Purchase | +650 | +0.40%165,124 | $1.72 | $1,117 | View SEC filing | |
| 2023-11-22 | Weisblum Eric CEO and President | Purchase | +4,350 | +2.72%164,474 | $1.60 | $6,948 | View SEC filing | |
| 2023-11-20 | Weisblum Eric CEO and President | Purchase | +2,900 | +1.84%160,124 | $1.46 | $4,235 | View SEC filing | |
| 2023-05-26 | Ryweck Daniel E. Chief Financial Officer | Purchase | +1,000 | +25.00%5,000 | $2.13 | $2,126 | View SEC filing | |
| 2023-05-18 | Weisblum Eric CEO and President | Purchase | +3,000 | +1.94%157,724 | $2.07 | $6,204 | View SEC filing | |
| 2022-12-20 | Weisblum Eric CEO and President | Purchase | +330 | +0.21%154,854 | $2.70 | $890 | View SEC filing | |
| 2022-12-15 | Weisblum Eric CEO and President | Purchase | +750 | +0.49%154,524 | $3.10 | $2,328 | View SEC filing | |
| 2022-06-21 | Weisblum Eric CEO, CFO and President | Purchase | +13,080 | +0.17%7,724,643 | $0.11 | $1,500 | View SEC filing | |
| 2021-12-15 | Weisblum Eric Chief Executive Officer | Purchase | +22,500 | +0.29%7,711,563 | $0.14 | $3,187 | View SEC filing | |
| 2021-05-17 | Weisblum Eric CEO, CFO and President | Purchase | +58,114 | +100.00%58,114 | $0.00 | $281 | View SEC filing |
1-23 of 23